Literature DB >> 16802602

The adapter 3BP2: how it plugs into leukocyte signaling.

Marcel Deckert1, Robert Rottapel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16802602     DOI： 10.1007/0-387-34132-3_8

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  17 in total

1.  Cherubism misdiagnosed as giant cell tumor: a case report and review of literature.

Authors:  Yang Jiao; Mi Zhou; Yaowu Yang; Jun Zhou; Xiaohong Duan
Journal:  Int J Clin Exp Med       Date:  2015-03-15

2.  3BP2 adapter protein is required for receptor activator of NFκB ligand (RANKL)-induced osteoclast differentiation of RAW264.7 cells.

Authors:  Amel GuezGuez; Virginie Prod'homme; Xavier Mouska; Alice Baudot; Claudine Blin-Wakkach; Robert Rottapel; Marcel Deckert
Journal:  J Biol Chem       Date:  2010-05-03       Impact factor: 5.157

3.  Body mass index is associated with gene methylation in estrogen receptor-positive breast tumors.

Authors:  Brionna Y Hair; Melissa A Troester; Sharon N Edmiston; Eloise A Parrish; Whitney R Robinson; Michael C Wu; Andrew F Olshan; Theresa Swift-Scanlan; Kathleen Conway
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-01-12       Impact factor: 4.254

4.  Decreased SH3BP2 inhibits osteoclast differentiation and function.

Authors:  Teruya Kawamoto; Chun Fan; Robert J Gaivin; Michael A Levine; Steven A Lietman
Journal:  J Orthop Res       Date:  2011-03-29       Impact factor: 3.494

5.  3BP2-deficient mice are osteoporotic with impaired osteoblast and osteoclast functions.

Authors:  Noam Levaot; Paul D Simoncic; Ioannis D Dimitriou; Andrew Scotter; Jose La Rose; Adeline H M Ng; Thomas L Willett; Chiachien J Wang; Salima Janmohamed; Marc Grynpas; Ernst Reichenberger; Robert Rottapel
Journal:  J Clin Invest       Date:  2011-07-18       Impact factor: 14.808

6.  The adaptor 3BP2 is required for KIT receptor expression and human mast cell survival.

Authors:  Erola Ainsua-Enrich; Eva Serrano-Candelas; Damiana Álvarez-Errico; César Picado; Joan Sayós; Juan Rivera; Margarita Martín
Journal:  J Immunol       Date:  2015-03-25       Impact factor: 5.422

Review 7.  Optimizing intracellular signaling domains for CAR NK cells in HIV immunotherapy: a comprehensive review.

Authors:  Giorgio Zenere; Omalla Allan Olwenyi; Siddappa N Byrareddy; Stephen E Braun
Journal:  Drug Discov Today       Date:  2019-02-13       Impact factor: 7.851

8.  Loss of Tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism.

Authors:  Noam Levaot; Oleksandr Voytyuk; Ioannis Dimitriou; Fabrice Sircoulomb; Arun Chandrakumar; Marcel Deckert; Paul M Krzyzanowski; Andrew Scotter; Shengqing Gu; Salima Janmohamed; Feng Cong; Paul D Simoncic; Yasuyoshi Ueki; Jose La Rose; Robert Rottapel
Journal:  Cell       Date:  2011-12-09       Impact factor: 41.582

9.  The adaptor 3BP2 is required for early and late events in FcεRI signaling in human mast cells.

Authors:  Erola Ainsua-Enrich; Damiana Alvarez-Errico; Alasdair M Gilfillan; César Picado; Joan Sayós; Juan Rivera; Margarita Martín
Journal:  J Immunol       Date:  2012-08-15       Impact factor: 5.422

10.  Tyrosine phosphorylation of 3BP2 regulates B cell receptor-mediated activation of NFAT.

Authors:  Upasana Shukla; Tomoko Hatani; Kenji Nakashima; Kazuhiro Ogi; Kiyonao Sada
Journal:  J Biol Chem       Date:  2009-10-15       Impact factor: 5.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.